28 February 2012 11:31 [Source: ICIS news]
LEVERKUSEN, Germany (ICIS)--Bayer CEO Marijn Dekkers said on Tuesday at the group’s financial news conference that innovation remains a central issue for the company.
“Many of the global challenges facing humankind cannot be overcome without innovative solutions. And theses global drivers are also important for us as a company,” he said.
“A growing, ageing population and increasing affluence in the emerging countries are boosting the demand for innovative healthcare solutions,” Dekkers added.
“On top of this comes the globally increasing demand for food – because the world population is predicted to grow from currently 7bn to more than 9bn by 2050. Since it is very difficult to increase the amount of arable land, that means new crop protection and seed products are needed to continue raising harvest yields,” he said.
Dekkers said Bayer needs innovations that it can commercialise as a precondition for further growth.
“Our task is to develop solutions in these areas. The key to this is to steadily strengthen our innovative capability.”
“We all work every day to build on our position as a world-class inventor company that improves the lives of many people with its innovative products and solutions,” he said.
Read Paul Hodges’s Chemical and the Economy blog
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections